Do thrombotic events during endovascular interventions lead to poorer outcomes in patients with severe limb ischemia?

Abstract

Introduction

Intra-procedural acute thrombosis (IPAT) is a complication of endovascular procedures. We aim to identify risk factors for IPAT and compare the outcomes of patients with or without IPAT.

Methods

Paired T test and χ² test were used to identify risk factors and short-term outcomes. Kaplan–Meier survival analysis was used for mid-term outcomes.

Results

A total of 228 procedures were performed with 21 IPAT events (9.21%). The odds ratio of Indian patients developing IPAT was 2.8x (95% CI 1.1–7.6). Patients with in-stent occlusion or prior IPAT were 5.6x (95% CI 1.3–24.2) and 5.6x (95% CI 1.3–24.4) more likely to develop an IPAT event. Patients without IPAT had significantly more improvement in mean runoff score (−1.15 ± 1.31, p < 0.01). The odds of patients with IPAT requiring subsequent endovascular intervention and arterial bypass surgery were 4.2x (95% CI 1.6–10.7) and 7.1x (95% CI 1.9–27.0). There was no significant Kaplan–Meier estimated overall survival or amputation-free survival difference between patients with or without IPAT event.

Conclusion

Indian ethnicity, in-stent occlusion and previous IPAT were associated with higher risk of IPAT. Even after successful endovascular salvage, patients with IPATs were more likely to require secondary revascularization procedure. Patients with IPATs had no decrease in overall survival or amputation-free survival.

Keywords

Acute thrombosis distal embolization endovascular intervention peripheral vascular disease

Get full access to this article

View all access options for this article.

References

Information paper on diabetes in Singapore. Singapore: National Registry of Diseases Office, 3 November 2011. Report No.: (INP-11-7).

White

. Non-surgical treatment of patients with peripheral vascular disease. Br Med Bull 2001; 59: 173–192.

De Sanctis

. Percutaneous interventions for lower extremity peripheral vascular disease. Am Fam Phys 2001; 64(12): 1965–1972.

Shammas

Dippel

. Predictors of distal embolization in peripheral percutaneous interventions: a report from a large peripheral vascular registry. J Invasive Cardiol 2009; 21(12): 628–631.

Lam

Shah

Faries

. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg 2007; 46(6): 1155–1159.

Siablis

Karnabatidis

Katsanos

. Outflow protection filters during percutaneous recanalization of lower extremities' arterial occlusions: a pilot study. Eur J Radiol 2005; 55(2): 243–249.

Shrikhande

Khan

Hussain

. Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions. J Vasc Surg 2011; 53(2): 347–352.

Karnabatidis

Katsanos

Kagadis

. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovas Ther 2006; 13(3): 269–280.

Davies

Bismuth

Saad

. Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg 2010; 24(1): 14–22.

10.

Lookstein

Lewis

. Distal embolic protection for infrainguinal interventions: how to and when? Tech Vasc Interv Radiol 2010; 13(1): 54–58.

11.

Rutherford

Baker

Ernst

. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26(3): 517–538.

12.

Engelhardt

Boos

Bruijnen

. Critical limb ischaemia: initial treatment and predictors of amputation-free survival. Eur J Vasc Endovasc Surg 2012; 43(1): 55–61.

13.

Kawarada O, Fujihara M, Higashimori A, et al. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. Epub ahead of print 21 March 2012.

14.

Shammas

Dippel

Coiner

. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 2008; 15(3): 270–276.

15.

Wholey

Toursarkissian

Postoak

. Early experience in the application of distal protection devices in treatment of peripheral vascular disease of the lower extremities. Catheter Cardiovasc Interv 2005; 64(2): 227–235.

16.

Konig

Pusich

Tepe

. Frequent embolization in peripheral angioplasty: detection with an embolism protection device (AngioGuard) and electron microscopy. Cardiovasc Interv Radiol 2003; 26(4): 334–339.

17.

Muller-Hulsbeck

Humme

Philipp Schafer

. Final results of the protected superficial femoral artery trial using the filterwire EZ system. Cardiovasc Interv Radiol 2010; 33(6): 1120–1127.

18.

Muller-Hulsbeck

Stolzmann

Liess

. Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. Radiology 2005; 235(2): 454–460.

19.

Wisgott

Kamusella

Andresen

. Treatment of femoropopliteal stenoses and occlusions with mechanical rotational catheters: comparison of results with the Rotarex and Pathway devices. J Cardiovasc Surg 2012; 53(2): 177–186.

20.

Chew

Nguyen

Owens

. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg 2005; 42(4): 695–701.

21.

Chong

Rowe

Weaver

. Impact of race on infrainguinal angioplasty and stenting. Ann Vasc Surg 2011; 25(2): 204–209.

22.

Zhao

Loke

Rankin

. Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose. Clin Pharmacol Ther 2004; 76(3): 210–219.

23.

Lee

Oldenburg

. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clin Pharmacol Ther 2006; 79(3): 197–205.